LASER PHARMACOLOGY AND ACHILLES TENDINOPATHY

抄録

The Achilles tendon, although the largest and strongest tendon in the human body, has been recognized as a weak point since classical times. In the case of Achilles, an arrow severed the tendon, but repetitive body load is what causes this problem for athletes. The whip effect of pronation in the running gait and potential intrinsic weakness or collagen deterioration with age makes the Achilles tendon very vulnerable. Poor results with conservative therapy and laser therapy (LT) prompted us to use a combination of LT and local infiltration with concomitant medication. The subjects were 100 successive athletes with chronic Achilles tendinopathy who had undergone conservative treatment for six months without positive results. This study used a combination of Photodynamic Therapy with Plenosol^® intradermal and 660nm LT, followed by a cooling down treatment using Ubiquinon, Ferrum and Cu+ + subcutaneous infiltration, LT with 660nm, 830nm and 904nm. After an average of 4 treatments in 14 days, healing was achieved in 16 days and training was resumed in 90% of the patients. With these results, it was concluded that a good knowledge of the interaction between laser and pharmacology could reduce treatment time, even for chronic cases of Achilles tendinopathy.